OXIGENAÇÃO POR MEMBRANA EXTRACORPÓREA (ECMO) NO TRATAMENTO DE PACIENTES COM COVID-19: REVISÃO SISTEMÁTICA
ECMO no tratamento de pacientes com COVID-19
DOI:
https://doi.org/10.13037/2359-4330.7944Keywords:
ECMO, Oxigenação por Membrana Extracorpórea, COVID-19Abstract
Introduction: The use of Extracorporeal Membrane Oxygenation (ECMO) has been studied in the treatment of patients with COVID-19, since this therapy has already shown favorable results in the treatment of acute respiratory failure of viral etiology, as in H1N1 influenza. Objectives: Analise the effectiveness of using ECMO in patients with severe acute respiratory failure caused by COVID-19. Material and Methods: For this purpose, a systematic literature review was carried out using the PICO structure (Patient, Intervention, Comparison and “Outcome”) to formulate the guiding question. Controlled descriptors (DECS) were used to select the articles: ("Extracorporeal Membrane Oxygenation *" OR ECMO OR "Extracorporeal Life Support *" OR ECLS) and ("COVID *" OR Coronavirus OR "SARS *"). The searches were made in the COCHRANE LIBRARY, PubMed, EMBASE and CINAHL databases. Revisions, editorials, congress abstracts and study protocols were excluded. The variables analyzed were: The benefits and safety of this treatment, as well as whether there was a reduction in the mortality rate, contraindications and risks with this treatment. Results: After consulting the databases, 292 articles were identified using the descriptors mentioned above, of which 11 were included in this study after the selection process. The patients who needed ECMO were predominantly elderly and had the following risk factors: systemic arterial hypertension (SAH), meningococcal disease (DM) and obesity. The main complications found were hemorrhagic and thromboembolic. Finally, the mortality rate varied considerably between studies and it was possible to observe a significant decrease among patients who received this treatment. Discussion: The main results of this systematic review showed that the patients in this study were predominantly elderly and had underlying diseases mainly systemic arterial hypertension (SAH), meningococcal disease (DM) and obesity.
Conclusion: Therefore, as it is a recently studied health condition, it is necessary that further studies be conducted to confirm the effectiveness of ECMO in patients with COVID-19.
Downloads
References
Associação de Medicina Intensiva Brasileira (AMIB). Preparação de URI para COVID-19: lições de experiências internacionais. São Paulo [acesso em 30 mai. 2020]. Disponível em: https://www.amib.org.br/noticia/nid/preparacao-de-uti-para-covid-19-licoes-de-experiencias-internacionais/
McIntosh K. Coronavirus disease 2019 (COVID-19). EUA [acesso em 01 jun. 2020]. Disponível em: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19.
Hong X, Xiong J, Feng Z, Shi Y. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19? Int J Infect Dis. 2020 May;94:78-80. doi: 10.1016/j.ijid.2020.03.058.
Zeng Y, Cai Z, Xianyu Y, Yang BX, Song T, Yan Q. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Crit Care. 2020 Apr 15;24(1):148. doi: 10.1186/s13054-020-2840-8.
Patel BK. Insuficiência respiratória hipoxêmica aguda (IRHA, SARA). EUA [acesso em 10 jun. 2020]. Disponivel em: https://www.msdmanuals.com/pt/profissional/medicina-de-cuidados-cr%C3%ADticos/insufici%C3%AAncia-respirat%C3%B3ria-e-ventila%C3%A7%C3%A3o-mec%C3%A2nica/insufici%C3%AAncia-respirat%C3%B3ria-hipox%C3%AAmica-aguda-irha,-sara.
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020. doi:10.1016/S2213-2600(20)30121-1.
Extracorporeal Life Support Organization. ECMO para pacientes com COVID-19 com insuficiência cardíaca e/ou pulmonar. EUA [Acesso em 02 Jun 2020]. Disponível em: https://www.elso.org/Portals/0/Files/Guideline/ELSO_COVID-19%20Guidance%20Document.Portugeuse%20(1).pdf.
World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected 2020. Suíça. [acesso em 30 maio.2020]. Disponível em: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
Barros L, Rivetti L, Furlanetto B, Teixeira E, Welikow A. COVID-19: general guidelines for cardiovascular surgeons (standard guidelines- subject to change). Brazilian Journal of Cardiovascular Surgery 2020. doi:10.21470/1678-9741-1-2020-0604
Beyls C, Huette P, Abou-Arab O, Berna P, Mahjoub Y. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis. Br J Anaesth. 2020;125(2):e260-e262. doi:10.1016/j.bja.2020.04.079.
Falcoz PE, Monnier A, Puyraveau M, Perrier S, Ludes PO, Olland A et al. Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort? Am J Respir Crit Care Med. 2020 Aug 1;202(3):460-463. doi: 10.1164/rccm.202004-1370LE.
Haye G, Fourdrain A, Abou-Arab O, Berna P, Mahjoub Y. COVID-19 Outbreak in France: Setup and Activities of a Mobile Extracorporeal Membrane Oxygenation Team During the First 3 Weeks [published online ahead of print, 2020 May 8]. J Cardiothorac Vasc Anesth. 2020;S1053-0770(20)30424-9. doi:10.1053/j.jvca.2020.05.004
Huette P, Beyls C, Guilbart M, Coquet A, Berna P, Haye G, Roger PA et al. Extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: outcome and time-course of clinical and biological parameters. Can J Anaesth. 2020 Oct;67(10):1486-1488. doi: 10.1007/s12630-020-01727-z.
Liu J, Dong YQ, Yin J, He G, Wu X, Li J, Qiu Y, He X. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study. Medicine (Baltimore). 2020 Jun 26;99(26):e21012. doi: 10.1097/MD.0000000000021012.
Loforte A, Dal Checco E, Gliozzi G, Benedetto M, Cavalli GG, Mariani C et al. Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience. ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198.
Marullo AG, Cavarretta E, Biondi-Zoccai G, Mancone M, Peruzzi M, Piscioneri F et al. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience. Minerva Cardioangiol. 2020 Apr 27. doi: 10.23736/S0026-4725.20.05328-1.
Osho AA, Moonsamy P, Hibbert KA, Shelton KT, Trahanas JM, Attia RQ et al. Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America. Ann Surg. 2020 Aug;272(2):e75-e78. doi: 10.1097/SLA.0000000000004084.
Sultan I, Habertheuer A, Usman AA, Kilic A, Gnall E, Friscia ME et al. The role of extracorporeal life support for patients with COVID-19: Preliminary results from a statewide experience. J Card Surg. 2020 Jul;35(7):1410-1413. doi: 10.1111/jocs.14583.
Yang X, Cai S, Luo Y, Zhu F, Hu M, Zhao Y et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
Li X, Guo Z, Li B, Zhang X, Tian R, Wu W et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. ASAIO J. 2020 May;66(5):475-481. doi: 10.1097/MAT.0000000000001172.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Kon ZN, Smith DE, Chang SH, Goldenberg RM, Angel LF, Carillo JA et al. Extracorporeal Membrane Oxygenation Support in Severe COVID-19. Ann Thorac Surg. 2020 Jul 17:S0003-4975(20)31152-8. doi: 10.1016/j.athoracsur.2020.07.002.
Rajagopal K, Keller SP, Akkanti B, Bime C, Loyalka P, Cheema FH et al. Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document. Circ Heart Fail. 2020 May;13(5):e007175. doi: 10.1161/CIRCHEARTFAILURE.120.007175.
Marodin G, Goldim JR. Confusiones y ambigüedades en la clasificación de eventos adversos en investigación clínica. Rev. esc. enferm. USP [Internet]. 2009 Sep [cited 2020 Oct 18] ;43(3):690-696. doi: 10.1590/S0080-62342009000300027.
Savarimuthu S, BinSaeid J, Harky A. The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill? J Card Surg. 2020 Jun;35(6):1298-1301. doi: 10.1111/jocs.14635.
Haiduc AA, Alom S, Melamed N, Harky A. Role of extracorporeal membrane oxygenation in COVID-19: A systematic review. J Card Surg. 2020 Oct;35(10):2679-2687. doi: 10.1111/jocs.14879.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Amanda Costa Araujo, Délcio Uezato Junior, Arthur Felipe Giambona Rente, Dafne Port Nascimento
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Policy Proposal for Journals offering Free Delayed Access
Authors who publish in this magazine agree to the following terms:
- Authors maintain the copyright and grant the journal the right to the first publication, with the work simultaneously licensed under a Creative Commons Attribution License after publication, allowing the sharing of the work with recognition of the authorship of the work and initial publication in this journal.
- Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (eg, publishing in institutional repository or as a book chapter), with the acknowledgment of the authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase impact and citation of the published work (See The Effect of Open Access).
